Impact BioMedical (IBO)

• Market cap: $53.7M
• 1 day: -7.47%
• 5 days: -6.09%
• 1 month: -2.79%
• 3 months: -19.73%
• 6 months: -2.43%
• Year to date: -4.01%
• 1 year: -40.75%
• 5 years: -81.43%
• 10 years: -81.43%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Employees: 8